Alberta Health Services: Tom Baker Cancer Centre

Calgary, Alberta T2N 4N2

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing, EGFR PACC, EGFR Uncommon Mutations, Metastatic Castrate-Resistant Prostate Cancer, Metastatic Non-Small-Cell Lung Cancer, Nasopharyngeal Carcinoma, Non-Small-Cell Lung Cancer, PSA, Prostate Cancer

Studies at this site

• Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations — Recruiting now
• A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma — Running, not enrolling
• OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone — Stopped early